TERT and glioblastoma: In contrast to germline mutations, somatic mutations in the TERT promoter occur more frequently and have been identified in several cancer types besides human melanoma, including glioblastoma, hepatocellular carcinomas, bladder cancers, thyroid cancers, and urothelial cancers [46].